The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery
Drug discovery and development are aimed at identifying new chemical molecular entities (NCEs) with desirable pharmacokinetic profiles for high therapeutic efficacy. The plasma concentrations of NCEs are a biomarker of their efficacy and are governed by pharmacokinetic processes such as absorption,...
Main Authors: | Hiroshi Komura, Reiko Watanabe, Kenji Mizuguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/11/2619 |
Similar Items
-
An Evolved Transformer Model for ADME/Tox Prediction
by: Changheng Shao, et al.
Published: (2024-02-01) -
Virtual Screening in Lead Discovery: A Viewpoint
by: Tudor Ionel Oprea
Published: (2002-01-01) -
Application of multiple linear regression analysis to predict antifungal activity of some benzimidazole derivatives using ADME parameters
by: Kalajdžija Nataša D., et al.
Published: (2013-01-01) -
In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
by: Ying Han, et al.
Published: (2019-04-01) -
In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity
by: Shivanand Kolageri, et al.
Published: (2022-09-01)